U.S Secondary Hyperparathyroidism Treatment (SHPT) Market Size Worth USD 7.06 Billion by 2026; Increasing Launch of Effective Drugs Will Create Growth Opportunities
November 18, 2019 09:00 ET
|
Fortune Business Insights
Pune, Nov. 18, 2019 (GLOBE NEWSWIRE) -- The increasing launch of effective drugs is a key factor driving the U.S. secondary hyperparathyroidism treatment market, says Fortune Business Insights in a...